Medtronic (MDT)
NYSE:MDT
Want to see MDT full AI Analyst Report?
Earnings Data
Report Date
Aug 25, 2026Before Open (Confirmed)
Period Ending
2027 (Q1)Consensus EPS Forecast
1.39Last Year’s EPS
1.26Same Quarter Last Year
Moderate Buy
Based on 22 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a predominantly positive operational and financial picture: strong quarterly and annual revenue growth, EPS outperformance, robust free cash flow, multiple high-growth product area accelerations (CAS, Symplicity, Hugo, Altaviva), and deliberate M&A/venture activity to drive future growth. Notable headwinds include tariffs and trade uncertainty, some product‑mix and Diabetes-related margin pressure, pockets of weakness in Structural Heart (TAVR) and select therapy areas, and near-term investment-driven SG&A/R&D increases. Management provided confident FY '27 guidance while conservatively modeling separation and tariff risks.Company Guidance
Quarterly and Full-Year Revenue Growth
Q4 revenue $9.8B, up 9.9% reported and 6.6% organic; FY '26 revenue $36.4B, up 8.4% reported and 5.8% organic — company’s strongest top-line performance in 10 years.
Earnings and Cash Flow Outperformance
Adjusted EPS: Q4 $1.55 and FY '26 $5.53, both ahead of expectations; free cash flow $5.4B for FY '26, strongest since 2022; cash & investments $9.2B at year-end.
Cardiac Ablation Solutions (CAS) Surge
CAS grew 78% worldwide (124% U.S.), gained ~8 percentage points of U.S. share; PFA grew ~145% globally; Affera installed base increased 40% sequentially and CAS is annualizing ~ $2B.
Strong Momentum in Renal Denervation (Symplicity)
Symplicity is annualizing at ~$100M; physician finder covers 200 doctors across 300+ accounts; average weekly procedure volumes doubled since NCD; long-term data: sustained mean systolic BP reductions of 13.3 mmHg (ambulatory) and 18.1 mmHg (in-office) at 3 years with 90% of patients achieving meaningful benefit.
Surgical Robotics and Digital Ecosystem Progress (Hugo / Touch Surgery)
Worldwide Hugo procedure volumes growing 2x–3x the market; U.S. urology launch completed with first patients treated; 510(k) submission for General Surgery/GYN and LigaSure RAS; Touch Surgery installs >1,400 (up 30%+ sequentially).
Altaviva Early Commercial Traction
Nearly 1,000 physicians trained since launch; active implanters up 3x sequentially and patients treated up 2.5x sequentially; device features same-day activation and up to 15 years longevity driving early adoption.
Portfolio Optimization and Targeted M&A/Venture Activity
Completed MiniMed IPO (spin), closed CathWorks, announced Scientia and SPR Therapeutics acquisitions and investments in Beluga Medical and CardioACC; expect ~ $150M inorganic revenue contribution to FY '27; venture investments ~ $250M across 16 deals in FY '26.
Improved Gross Margin and Operational Efficiency
Adjusted gross margin 65.4%, up 30 bps year-over-year and 50 bps sequentially; pricing +30 bps and COGS efficiency net of inflation contributed ~60 bps; adjusted operating margin 25.5% and adjusted operating profit $2.5B.
Confident FY '27 Guidance
Guidance of FY '27 organic revenue growth 6.75%–7.25% (Q1 organic ~11.5%–12% including extra selling week); FY '27 EPS guidance $5.90–$6.00; expect operating margin to be ~60 bps higher year-over-year (excludes tariffs).
MDT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MDT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jun 03, 2026 | $73.75 | $77.95 | +5.69% |
Feb 17, 2026 | $98.68 | $95.63 | -3.10% |
Nov 18, 2025 | $94.80 | $99.25 | +4.69% |
Aug 19, 2025 | $90.70 | $87.85 | -3.14% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Medtronic (MDT) report earnings?
Medtronic (MDT) is schdueled to report earning on Aug 25, 2026, Before Open (Confirmed).
What is Medtronic (MDT) earnings time?
Medtronic (MDT) earnings time is at Aug 25, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MDT EPS forecast?
MDT EPS forecast for the fiscal quarter 2027 (Q1) is 1.39.
